[Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy]
Rebollo Aguirre AC, Villegas Portero R, Ramos Font C
Record ID 32008100427
Spanish
Authors' objectives:
The aim of the present report was assessing the performance of positron emission tomography (PET or PET-CT with fluordeoxyglucose -F18, as diagnostic test, in assessing the response to neoadjuvant treatment of patients with oesophagus cancer, breast cancer, non-small cell lungs cancer (NSCLC), in terms of diagnostic validity and clinical utility.
Details
Project Status:
Completed
URL for project:
http://www.juntadeandalucia.es/salud/servicios/contenidos/nuevaaetsa/up/AETSA_2006-15_PET_FDG.pdf
Year Published:
2009
URL for published report:
http://www.juntadeandalucia.es/salud/servicios/contenidos/nuevaaetsa/up/AETSA_2006-15_PET_FDG_eng.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Spain
MeSH Terms
- Breast Neoplasms
- Esophageal Neoplasms
- Lung Neoplasms
- Lymphoma
- Positron-Emission Tomography
Contact
Organisation Name:
Andalusian Health Technology Assessment Area
Contact Address:
Area de Evaluacion de Tecnologias Sanitarias Sanitarias de Andalucia (AETSA) Avda. Innovación, s/n Edificio Arena 1. Sevilla (Spain) Tel. +34 955 006 309
Contact Name:
aetsa.csalud@juntadeandalucia.es
Contact Email:
aetsa.csalud@juntadeandalucia.es
Copyright:
Andalusian Agency for Health Technology Assessment (AETSA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.